TGF-β1 suppression of microRNA-450b-5p expression: a novel mechanism for blocking myogenic differentiation of rhabdomyosarcoma
Authors:
- 13 May 2013
- journal article
- Published by Springer Nature in Oncogene
- Vol. 33 (16) , 2075-2086
Abstract
Transforming growth factor beta 1 (TGF-β1) is the most potent inhibitor of myogenic differentiation (MyoD) of rhabdomyosarcoma (RMS); however, the underlying mechanisms of this inhibition remain unclear. In this study, we identified novel TGF-β1-related microRNAs (miRNAs); among these, miR-450b-5p is significantly regulated by TGF-β1. We provide evidence that TGF-β1 exerts it function by suppressing miR-450b-5p. Both in cultured cells and tumor implants, miR-450b-5p significantly arrested the growth of RMS and promoted its MyoD. Utilizing a bioinformatics approach, we identified miR-450b-5p target mRNAs. Among these candidates, only the expression of ecto-NOX disulfide-thiol exchanger 2 (ENOX2) and paired box 9 (PAX9) was augmented by miR-450b-5p knockdown examined by western blot; the engineered inhibition antagonized TGF-β1-mediated differentiation inhibition. Furthermore, we found that the Smad3 and Smad4 pathways, but not Smad2, are the principal mediator of TGF-β1 suppression of miR-450b-5p. Taken together, these results suggest that disrupting the TGF-β1 suppression of miR-450b-5p, or knockdown of ENOX2 and PAX9, are effective approaches in inducing RMS MyoD.Keywords
This publication has 33 references indexed in Scilit:
- TGF‐β1 signal pathway may contribute to rhabdomyosarcoma development by inhibiting differentiationCancer Science, 2010
- Selection of optimal sites for TGFB1 gene silencing by chitosan–TPP nanoparticle-mediated delivery of shRNACancer Genetics and Cytogenetics, 2009
- MicroRNA-Based Therapeutics for CancerBioDrugs, 2009
- MicroRNA-155 Is Regulated by the Transforming Growth Factor β/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoAMolecular and Cellular Biology, 2008
- SMAD proteins control DROSHA-mediated microRNA maturationNature, 2008
- Transforming growth factor- -regulated miR-24 promotes skeletal muscle differentiationNucleic Acids Research, 2008
- Molecular therapy in the microRNA eraThe Pharmacogenomics Journal, 2006
- Transforming Growth Factor-β1 Induces the Differentiation of Myogenic Cells into Fibrotic Cells in Injured Skeletal MuscleThe American Journal of Pathology, 2004
- Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas: Figure 1Journal of Clinical Pathology, 2003
- Deficiency in Rhabdomyosarcomas of a Factor Required for MyoD Activity and MyogenesisScience, 1993